Related Experiment Video
Updated: May 17, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Diabetic cardiomyopathy and metabolic remodeling of the heart
Pavan K Battiprolu1, Camila Lopez-Crisosto, Zhao V Wang
1Department of Internal Medicine (Cardiology), University of Texas Southwestern Medical Center, Dallas, TX 75235, USA.
Insights
Diabetic cardiomyopathy harms the heart independently of other conditions. Understanding its unique metabolic pathways offers new therapeutic targets for heart disease in diabetes patients.
Area of Science:
- Cardiology
- Metabolic Diseases
- Pathophysiology
Background:
- Diabetes mellitus incidence and prevalence are rising globally.
- Diabetes significantly increases heart disease risk, often due to atherosclerosis and hypertension.
- Diabetic cardiomyopathy is a distinct cardiac condition developing independently of other risk factors.
Purpose of the Study:
- To review recent insights into the pathogenesis of diabetic cardiomyopathy.
- To explore metabolic remodeling associated with diabetic heart disease.
- To identify novel therapeutic targets for diabetes-specific heart disease.
Main Methods:
- Review of recent scientific literature.
- Analysis of studies on diabetic cardiomyopathy pathogenesis.
- Investigation of metabolic remodeling in diabetic hearts.
Main Results:
- Diabetic milieu directly impacts heart physiology, structure, and function.
- Diabetic cardiomyopathy involves unique pathogenic mechanisms.
- Current therapies focus on glucose control and late-stage heart failure management.
Conclusions:
- Diabetic cardiomyopathy presents unique challenges requiring diabetes-specific interventions.
- Understanding novel pathogenic pathways is crucial for developing targeted therapies.
- Future research should focus on identifying and validating new therapeutic targets.
Abstract:
The incidence and prevalence of diabetes mellitus are both increasing rapidly in societies around the globe. The majority of patients with diabetes succumb ultimately to heart disease, much of which stems from atherosclerotic disease and hypertension. However, the diabetic milieu is itself intrinsically noxious to the heart, and cardiomyopathy can develop independent of elevated blood pressure or coronary artery disease. This process, termed diabetic cardiomyopathy, is characterized by significant changes in the physiology, structure, and mechanical function of the heart. Presently, therapy for patients with diabetes focuses largely on glucose control, and attention to the heart commences with the onset of symptoms. When the latter develops, standard therapy for heart failure is applied. However, recent studies highlight that specific elements of the pathogenesis of diabetic heart disease are unique, raising the prospect of diabetes-specific therapeutic intervention. Here, we review recently unveiled insights into the pathogenesis of diabetic cardiomyopathy and associated metabolic remodeling with an eye toward identifying novel targets with therapeutic potential.
More Related Videos
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care